Finally, our study shows the feasibility of inhibiting IKKε and its downstream signalling, in particular the SBP, as shown by our recent work (https://biorxiv.org/cgi/content/short/855361v1), as preventive strategy to reduce the risk of breast cancer associated with obesity. Here, IKBKE is linked to obesity disorder.